Skip to main content

Advertisement

Log in

Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Factors of early and late recurrence after curative resection of hepatocellular carcinoma (HCC) may be different. The aim of this study was to identify clinical factors, including liver stiffness measurement (LSM), which are associated with HCC recurrence after curative resection.

Methods

Patients who underwent preoperative LSM and primary curative resection for HCC between October 2015 and May 2018 were retrospectively reviewed, with 1 year as the cut-off between early and late recurrence.

Results

Recurrence was observed in 42/149 (28.2%) patients over a median follow-up of 38.3 months (early recurrence: 10 [6.7%] patients; late recurrence: 32 [21.5%] patients). Multivariate analysis identified LSM (P = 0.026) and tumor size (P = 0.010) as the only factors that were significantly associated with recurrence-free survival. Compared with patients without recurrence, those with early recurrence had larger tumor size (P = 0.035) and those with late recurrence had higher LSM (P = 0.024). Receiver-operating characteristic analysis indicated that the optimal LSM cut-off value for predicting HCC recurrence was 7.4 kPa.

Conclusion

Tumor size was associated with early HCC recurrence after curative resection and LSM was associated with late recurrence. LSM cut-off of 7.4 kPa is recommended in predicting recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lupberger J, Hildt E (2007) Hepatitis B virus-induced cncogenesis. World J Gastroenterol 13:74–81

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Bruix J, Reig M, Sherman M (2016) Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150:835–853

    PubMed  Google Scholar 

  3. El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752–1763

    PubMed  Google Scholar 

  4. Chen JA, Shi M, Li JQ et al (2010) Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatol Int 4:537–547

    PubMed  PubMed Central  Google Scholar 

  5. Tsai TJ, Chau GY, Lui WY et al (2000) Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 127:603–608

    CAS  PubMed  Google Scholar 

  6. Cha C, Fong Y, Jarnagin WR et al (2003) Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 197:753–758

    PubMed  Google Scholar 

  7. Nagano Y, Shimada H, Takeda K et al (2008) Predictive factors of microvascular invasion in patients with hepatocellular carcinoma larger than 5 cm. World J Surg 32:2218–2222

    PubMed  Google Scholar 

  8. Sumie S, Kuromatsu R, Okuda K et al (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15:1375–1382

    PubMed  Google Scholar 

  9. Lee S, Kang TW, Song KD et al (2019) (2019) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. https://doi.org/10.1097/SLA.0000000000003268

    Article  PubMed  Google Scholar 

  10. Sasaki Y, Imaoka S, Masutani S et al (1992) Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 112:515–521

    CAS  PubMed  Google Scholar 

  11. Poon RT, Fan ST, Ng IO et al (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89:500–507

    CAS  PubMed  Google Scholar 

  12. Yamamoto J, Kosuge T, Takayama T et al (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83:1219–1222

    CAS  PubMed  Google Scholar 

  13. Nagasue N, Uchida M, Makino Y et al (1993) Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105:488–494

    CAS  PubMed  Google Scholar 

  14. Kim BK, Fung J, Yuen MF et al (2013) Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 19:1890–1900

    PubMed  PubMed Central  Google Scholar 

  15. Jung KS, Kim SU, Choi GH et al (2012) Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (Fibroscan®). Ann Surg Oncol 19:4278–4286

    PubMed  Google Scholar 

  16. Jung KS, Kim JH, Kim SU et al (2014) Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model. PLoS ONE 9:1–7

    Google Scholar 

  17. Shimada M, Takenaka K, Taguchi K et al (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80–85

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Feo F, Pascale RM (2015) Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis? Ann Transl Med 3:1–5

    Google Scholar 

  19. Arii S, Monden K, Niwano M et al (1998) Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg 5:86–92

    CAS  PubMed  Google Scholar 

  20. Hirokawa F, Hayashi M, Asakuma M et al (2016) Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma. Surg Oncol 25:24–29

    PubMed  Google Scholar 

  21. Hong YM, Cho M, Yoon KT et al (2017) Risk factors of early recurrence after curative hepatectomy in hepatocellular carcinoma. Tumor Biol 39:1–9

    Google Scholar 

  22. Portolani N, Coniglio A, Ghidoni S et al (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243:229–235

    PubMed  PubMed Central  Google Scholar 

  23. Shimoda M, Tago K, Shiraki T et al (2016) Risk factors for early recurrence of single lesion hepatocellular carcinoma after curative resection. World J Surg 40:2466–2471

    PubMed  Google Scholar 

  24. Xin L, Haitao Z, Huayu Y et al (2009) A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy. J Surg Oncol 100:488–493

    Google Scholar 

  25. Wu JC, Huang YH, Chau GY et al (2009) Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol 51:890–897

    PubMed  Google Scholar 

  26. Cheng Z, Yang P, Qu S et al (2015) Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB 17:422–427

    PubMed  Google Scholar 

  27. Xing H, Zhang WG, Cescon M et al (2020) Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study. HPB 22:677–689

    PubMed  Google Scholar 

  28. Zhou L, Rui JA, Wang SB et al (2013) Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 12:68–73

    PubMed  Google Scholar 

  29. Sun HC, Zhang W, Qin LX et al (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47:684–690

    CAS  PubMed  Google Scholar 

  30. Pan HW, Ou YH, Peng SY et al (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular cacinoma. Cancer 98:119–127

    CAS  PubMed  Google Scholar 

  31. Shah SA, Greig PD, Gallinger S et al (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283

    PubMed  Google Scholar 

  32. Meguro M, Mizuguchi T, Nishidate T et al (2015) Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients. World J Gastroenterol 21:4933–4945

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Kim DY, Paik YH, Ahn SH et al (2007) PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 72:52–57

    CAS  PubMed  Google Scholar 

  34. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200–207

    PubMed  Google Scholar 

  35. Du ZG, Wei YG, Chen KF et al (2014) Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreat Dis Int 13:153–161

    CAS  PubMed  Google Scholar 

  36. Belghiti J, Panis Y, Farges O et al (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Cho A, Chung YE, Choi JS et al (2017) Feasibility of preoperative FDG PET/CT total hepatic glycolysis in the remnant liver for the prediction of postoperative liver function. Am J Roentgenol 208:624–631

    Google Scholar 

  38. Rajakannu M, Cherqui D, Ciacio O et al (2017) Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma. Surgery 162:766–774

    PubMed  Google Scholar 

  39. Marcellin P, Ziol M, Bedossa P et al (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242–247

    PubMed  Google Scholar 

  40. Ziol M, Handra-Luca A, Kettaneh A et al (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54

    PubMed  Google Scholar 

  41. Wong VW, Vergniol J, Wong GL et al (2010) Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51:454–462

    CAS  PubMed  Google Scholar 

  42. Nguyen-Khac E, Chatelain D, Tramier B et al (2008) Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 28:1188–1198

    CAS  PubMed  Google Scholar 

  43. Akima T, Tamano M, Hiraishi H (2011) Liver stiffness measured by transient elastography is a predictor of hepatocellular carcinoma development in viral hepatitis. Hepatol Res 41:965–970

    PubMed  Google Scholar 

  44. Masuzaki R, Tateishi R, Yoshida H et al (2009) Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 49:1954–1961

    PubMed  Google Scholar 

  45. Lee YR, Park SY, Kim SU et al (2017) Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation. J Gastroenterol Hepatol 32:1079–1086

    CAS  PubMed  Google Scholar 

  46. Izumi T, Sho T, Morikawa K et al (2019) Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter. Hepatol Res 49:1207–1217

    PubMed  Google Scholar 

  47. Jung KS, Kim SU, Ahn SH et al (2011) Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 53:885–894

    CAS  PubMed  Google Scholar 

  48. Cho HJ, Kim B, Kim HJ et al (2020) Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. Eur Radiol 30:4182–4192

    PubMed  Google Scholar 

  49. Tabrizian P, Jibara G, Shrager B et al (2015) Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg 261:947–955

    PubMed  Google Scholar 

Download references

Funding

The authors of this manuscript have no conflicts of interest to disclose. The study received no grant support. The study was approved by the Institutional Review Board of the Seoul National University Hospital (No. H-1809–001-967). The requirement for informed consent was waived because of the retrospective nature of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung-Suk Suh.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hong, S.K., Jin, XL., Suh, S. et al. Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma. World J Surg 46, 197–206 (2022). https://doi.org/10.1007/s00268-021-06308-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-021-06308-9

Navigation